Keywords: Actelion, Fiancial results 2010

Actelion full-year 2010 results below forecast but sales strong

Article | 18 February 2011

Print This

Swiss biotech firm Actelion (SIX: ATLN), which is facing pressure from a shareholder to oust its chairman and chief executive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in